News
Aging is the primary risk factor for neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis ...
You'll get access to an ad-free website with a faster photo browser, the chance to claim free tickets to a host of events ...
A recent population-based study published in the Journal of American Medical Association identified a modest increase in ...
Dr Ethan Melillo, a pharmacist from Rhode Island, reveals one of the medications he 'hates' for its harmful side effects in ...
A 12-month clinical trial investigated whether a cough medicine used in Europe called Ambroxol can slow dementia in people with Parkinson’s.
Bi-partisan legislation was introduced in the U.S. House of Representatives to get primary care physicians more training on ...
A 12-month study found that Ambroxol helped stabilised psychiatric symptoms and protected against brain damage in genetically ...
After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...
A surprising discovery about how brain cells handle sugar could shift how scientists approach dementia and Alzheimer’s ...
Updated label allows Neuraceq to be used in selecting patients for amyloid-targeting therapies and includes the use of ...
Sundowning is a common symptom in people with dementia, especially Alzheimer’s disease. It refers to a pattern where someone ...
In summary, while there is no guaranteed way to prevent dementia, taking blood pressure medication as prescribed may help ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results